Pharmacopoeia Commission for Indian medicine and homeopathy achieves key BIS, IMS certifications
New Delhi, Sep 4 (IANS) Marking a milestone for the Ayush sector, the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) on Wednesday announced that it achieved the Bureau of Indian Standards (BIS) Integrated Management System (IMS) certifications. “his achievement marks a significant advancement for the Ayush sector, paving the way for enhanced global recognition
New Delhi, Sep 4 (IANS) Marking a milestone for the Ayush sector, the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) on Wednesday announced that it achieved the Bureau of Indian Standards (BIS) Integrated Management System (IMS) certifications.
“his achievement marks a significant advancement for the Ayush sector, paving the way for enhanced global recognition and setting a new standard for excellence in Indian Medicine and Homeopathy,” the Ayush Ministry said.
It noted that the PCIM&H has been awarded with IS/ISO 9001:2015 for Quality Management System (QMS), IS/ISO 14001:2015 for Environmental Management System (EMS) and IS/ISO 45001:2018 for Occupational Health & Safety Management System (OHSMS).
The certifications not only enhance PCIM&H’s operational efficiency but also support the Ministry of Ayush’s mission to promote high standards in Ayurveda, Siddha, Unani, and Homoeopathy.
“This certification system will help PCIM&H to enhance the operational efficiency and also will help to meet global quality standards. PCIM&H is developing the quality standards for Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) drugs in the form of Pharmacopoeia,” said Dr Raman Mohan Singh, Director of PCIM&H.
“The IMS certification system will help to assure the adherence to international acceptance of the pharmacopoeia standards developed by PCIM&H for ASU&H drugs,” he added.
These certifications, granted by BIS, reflect the Commission’s dedication to adhering to international standards. While the Quality Management System certification affirms PCIM&H’s ability to consistently meet and exceed customer expectations, the environmental management system certification highlights the organisation’s commitment to reducing its environmental impact and fostering sustainable practices. Further, the occupational health and safety management system certification shows the Commission’s proactive measures in maintaining a safe and healthy work environment.
–IANS
rvt/vd
Odisha: State-Level Management Committee Meeting on Subhadra Yojana Held
Next Articleମହାପ୍ରଭୁଙ୍କ ପ୍ରତି ନିଜ ଅନନ୍ୟ ଭକ୍ତି ସ୍ୱରୂପ ଗୋଟିଏ ମାସର ଦରମା ପ୍ରଦାନ କଲେ କୃଷି ବିଭାଗ ଅଧିକାରୀ ସୁଜାତା ପ୍ରୟମ୍ବଦା
Related Articles
New AI tool to revolutionise personalised cancer treatment

स्वास्थ्य व लाइफस्टाइलNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

स्वास्थ्य व लाइफस्टाइलCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

स्वास्थ्य व लाइफस्टाइलGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
